SAEMF/Global Emergency Medicine Academy (GEMA) Research Pilot Grant
Status: ClosedThe following is an overview of the SAEMF/GEMA Research Pilot Grant. For complete instructions on applying, please see the Detailed Instructions. For submission instructions and SAEMF policies, visit How To Apply. For answers to other common questions, visit our Grants FAQ, or email email@example.com.
Application Deadline: August 1, 2019
All application components, including letters of support, must be submitted electronically in a single file (PDF format only) attached to an email to firstname.lastname@example.org. The subject line of the email should indicate the grant for which the applicant is applying (GEMAResearch Pilot Grant).
All applications must be received by 5 pm (Central time) on their due date. No additional material (e.g. updates, publications, corrections, etc.) will be accepted after the application deadline.
Applicants must use the most current version of the National Institutes of Health (NIH) PHS 398 forms which can be downloaded at: http://grants1.nih.gov/grants/funding/phs398/phs398.html#forms. If there are questions regarding formatting, formatting which conforms to NIH guidelines will always be accepted.
The latest NIH biosketch format should be used.
Font type and size for the application should be Arial 11 point, including literature cited. Single line spacing is acceptable. Figures, charts, tables, and legends or captions may be in smaller size font but must be clear and legible.
Blank/plain paper can be used as needed in lieu of continuation pages when no form is specified to be used. The margins must be top: 0.8, bottom: 0.5, left: 0.5, right: 0.5.
The application for the SAEM GEMA Research Pilot Grant consists of the following components. Please use NIH form where applicable (https://grants.nih.gov/grants/forms/format-pages.htm). Only complete applications will be reviewed.
1. Research Proposal
a. Project summary and relevance
b. Performance sites
c. Candidate biosketch
d. Mentor and co-mentor(s) (if applicable) biosketch
e. Research strategy (total 4 pages)
i. Specific aims and hypotheses (one page)
f. Budget (one page)
h. Bibliography (with PMCID)
2. Personal Statement outlining career goals and specific training goals on this project (one page)
3. Letters of Support
a. Mentor – The mentor and co-mentor(s) (if applicable) must each document their role and willingness to participate in the project and explain how they will contribute to the development of the candidate's research career.
b. Department Chair or Divsision Chief – The institution should provide a document on institutional letterhead that describes its commitment to the candidate and the candidate’s career development. It is also essential to document the institution's commitment to the retention, development, and advancement of the candidate during the period of the award.
c. Residency or Fellowship Director - Must describe the actions that will be taken to ensure that the candidate can devote the required time to the research project.
PURPOSE OF THE AWARD
The SAEMF GEMA Research Pilot Grant is intended to provide financial support for a junior researcher in the field of international emergency medicine to enter a mentored project. This grant is not intended to support an independent research project, but instead to support the mentee’s role in a larger or existing project related to international emergency medicine/global health. Frequently there is a financial barrier to field travel for junior researchers participating in a mentored project. This grant is meant to support the travel costs of the awardee as well as minor direct research costs to allow for field participation in a project. This grant will fund travel-related expenses for the awardee only (e.g., economy airfare, hotel/housing, mobile data, and meals) and some direct project costs (e.g., software, data analysis, translation service, in-field staff costs) but will not support institutional buy-down/effort of either the mentor or the awardee or the purchase of hardware.
EXPECTATIONS OF PROJECTAll projects will be considered, such as education-related projects, lab-based research projects, qualitative research projects, and epidemiological projects. Projects will be scored based on their significance, impact and feasibility.
The applicant should be a junior researcher (senior resident/fellow/instructor/assistant professor) considering a career in academic emergency medicine with a focus on global health. Specific requirements are listed below:
1. Current member of GEMA at time of application and during the entire award period.
2. Possess a medical degree (MD or DO).
3. Current affiliation with the department/division of emergency medicine at an academic institution at the time of the application and during the entire award period, meeting at least one of the following three criteria:
a. Resident in Emergency Medicine
b. Fellow in an Emergency Medicine supported fellowship
c. Junior faculty member at the clinical instructor or assistant professor level
4. Support of a mentor/research director who is willing to supervise the completion of the research project.
5. An existing or planned project in which the applicant will participate in and which will require travel for a minimum of 6 weeks.
6. Has not previously been awarded a GEMA research grant.
The Mentor(s)The applicant’s mentor should have an established track record of mentoring junior researchers in research or in the field of international emergency medicine. He or she should have an ongoing or planned project in this field that requires participation of a junior researcher. He or she must commit to the necessary time to provide training and guidance to the awardee, as well as the resources and support required to bring the project to completion.
This is an award of $10,000 that must be used within the grant period. All spending must be outlined in the approved budget. Funds will only be released once IRB approval from both the parent academic institution and host institution have been provided. Any unused funds will be returned to SAEMF.
DURATION OF THE AWARD
The award is for one year (July 1, 2019 – June 30, 2020). Previous award recipients are not eligible for a second award.
PROGRESS REPORTSA progress report is due on December 1 subsequent to the start of the grant period. The final project and financial report are due June 30th at the end of the grant period. The progress report template can be downloaded at Post Award. These reports will be prepared independently by the awardee and mentor and submitted to SAEMF.
GRANT REVIEW PROCESS
The Grants Committee is responsible for the review of all applications and will make recommendations to the SAEMF Board of Trustees regarding recipients. A scoring system considering the qualifications of the applicant (and mentor, if applicable), the research proposal, the training proposal, and the institution will be assessed with the goal of funding applicants with the highest likelihood of becoming independently-funded scientists in emergency medicine.
CONTACT INFORMATIONPlease email the SAEM Grants Committee at email@example.com with any questions related to this grant.
Updated May 24, 2018
POLICIES GOVERNING THE USE OF HUMANS AND ANIMALS
If human or animal experimentation is to be performed during the period of the award, the department and institution to be used as the training site must affirm that: (1) investigations involving human subjects proposed and subsequently carried out in the application have been endorsed and approved by the IRB, or other clearly designated appropriate body, at the study site; (2) any research involving human subjects will conform ethically with the guidelines prescribed by the NIH; and (3) research involving animals will conform with the current "Guide for the Care and Use of Laboratory Animals", NIH publication, of the Department of Health and Human Services/United States Public Health Service (DHHS/USPHS), and has been approved by the Animal Care and Use Committee at the study site.
INVESTIGATORY FINANCIAL DISCLOSURE POLICY/OBJECTIVITY IN RESEARCH
Applicants and institutions are required by SAEMF to comply with the USPHS regulations, Final Rule, 42 CFR Part 50, Subpart F: Responsibility of Applicants for Promoting Objectivity in Research. The applicant’s and mentor’s institution or host institution official’s signature on the signature page of the application indicates compliance that an institutional administrative process is in effect to identify and resolve conflicting financial interests of the type described in Subpart 50.604(a) with respect to all projects for which funding is sought from SAEMF.
PATENT, INTELLECTUAL PROPERTY, AND TECHNOLOGY TRANSFER POLICY
All inventions discovered or arising out of research supported in whole or in part by SAEMF, which may be used in emergency medicine research, teaching, or practice, shall be reported within one (1) year to SAEMF. "Invention" is any discovery, material, method, process, product, program, software or app (mobile, application software, web application, etc) of use, whether or not patented or patentable or copyrighted or copyrightable, that has application of value such that its use, licensing, lease, or sale can generate revenue.
If the institution receiving or disbursing SAEMF funds that supported the invention has an established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF will defer to that policy. If the institution has no established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF shall have the right to determine the disposition of invention rights. In such cases, SAEMF may:
- Determine that patent and copyright should be or should not be filed;
- Release the invention to the inventor(s) or inventor's designee;
- Submit the invention to a qualified organization for administration and licensing;
- Determine by negotiation the fair share of royalty income to be paid to the inventor(s);
- License or make other arrangements for the application and use of the invention with terms on exclusivity and royalty payments determined by SAEMF.